🇺🇸 FDA
Patent

US 10124043

Mutant OPAA enzymes with increased catalytic efficiency on organophosphorus compound EA1356

granted A61KA61K38/465

Quick answer

US patent 10124043 (Mutant OPAA enzymes with increased catalytic efficiency on organophosphorus compound EA1356) held by The United States of America as represented by the Secretary of the Army expires Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America as represented by the Secretary of the Army
Grant date
Tue Nov 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 08 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/465